NCT05183776View on ClinicalTrials.gov

Clinical Validation of a Fractional Administration Device for Holmium-166 SIRT

NACompletedINTERVENTIONAL
Enrollment

5

Participants

Timeline

Start Date

July 12, 2022

Primary Completion Date

August 8, 2023

Study Completion Date

August 8, 2023

Conditions
Liver CancerLiver Metastasis Colon CancerPrimary Liver Cancer
Interventions
DEVICE

Fractional administration device

The novel fractional administration device enable the administration of the microspheres in fractions determined by the user. For this study, 5 fractions of 20% will be administered and validated using MRI.

Trial Locations (1)

Unknown

RadboudUMC, Nijmegen

All Listed Sponsors
collaborator

Terumo Medical Corporation

INDUSTRY

lead

Radboud University Medical Center

OTHER